FDA
-
-
-
-
-
-
-
BriaCell adds Penn Medicine cancer center to phase 3 breast cancer trial
-
-
-
-
-
-
-
BriaCell reports extended survival in metastatic breast cancer trial
-
-
-
-
-
-
-
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
-
-
-
-
-
-
-
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
-
-
-
-
-
-
-
BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer
-
-
-
-
-
-
-
BriaCell Reports Positive Breast Cancer Efficacy Data with Bria-IMT™ Immunotherapy Treatment at SITC Annual Meeting
-
335,363 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


